#TxID physician at @NM_IDSteward focusing on donor-derived and viral infections, Director of @NUCATSInstitute CCR & Editor-in-Chief @TheTxIDjournal
Aug 12, 2021 • 12 tweets • 8 min read
As we are on the cusp of authorization of a 3rd dose of #SARSCoV2#Vaccine for immunocompromised, I think its time for the entire Transplant Community begin focusing on some important questions that this entire situation has brought up
1/X1. Transplant patients have reduced protection from all vaccines compared to healthy controls, so the poor response was predicted. Why wasn’t there an a priori plan to study this? Many advocated for studies, but there were no @NIH or #Pharma funding mechanisms
2/x